Furthermore, we observed that SC-PLE and S-PLE can improve hepatic lipid metabolism abnormalities and insulin resistance by modulating lipid synthesis, fatty acid beta-oxidation, and the IRS/PI3K signaling pathway. The gene discussed is IARS1; the disease is Insulin resistance.